FARALLON CAPITAL MANAGEMENT LLC - Q4 2016 holdings

$8.68 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 71 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 138.1% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRcall$1,582,592,0007,080,000
+100.0%
18.22%
NXPI BuyNXP SEMICONDUCTORS N V$312,162,000
+3725.0%
3,185,000
+3881.2%
3.60%
+2921.0%
GOOG BuyALPHABET INCcap stk cl c$300,324,000
+38.9%
389,111
+39.9%
3.46%
+9.4%
Q NewQUINTILES IMS HOLDINGS INC$276,433,0003,634,880
+100.0%
3.18%
CHTR BuyCHARTER COMMUNICATIONS INC Ncl a$273,760,000
+17.8%
950,821
+10.4%
3.15%
-7.2%
BEAV NewB/E AEROSPACE INC$245,876,0004,085,000
+100.0%
2.83%
FLT BuyFLEETCOR TECHNOLOGIES INC$243,760,000
+50.4%
1,722,439
+84.6%
2.81%
+18.5%
V NewVISA INC$206,367,0002,645,051
+100.0%
2.38%
TWX NewTIME WARNER INC$202,230,0002,095,000
+100.0%
2.33%
WWAV NewWHITEWAVE FOODS CO$200,994,0003,615,000
+100.0%
2.31%
MSFT BuyMICROSOFT CORP$195,982,000
+73.5%
3,153,885
+60.8%
2.26%
+36.7%
CTXS BuyCITRIX SYS INC$190,667,000
+74.3%
2,134,892
+66.4%
2.20%
+37.4%
DVMT BuyDELL TECHNOLOGIES INC$189,726,000
+23.3%
3,451,440
+7.2%
2.18%
-2.8%
INFO BuyIHS MARKIT LTD$187,711,000
+23.9%
5,301,062
+31.4%
2.16%
-2.4%
CMCSA NewCOMCAST CORP NEWcl a$174,497,0002,527,110
+100.0%
2.01%
TMH NewTEAM HEALTH HOLDINGS INC$160,113,0003,685,000
+100.0%
1.84%
PCLN BuyPRICELINE GRP INC$134,219,000
+22.9%
91,551
+23.3%
1.55%
-3.2%
MJN NewMEAD JOHNSON NUTRITION CO$133,627,0001,888,453
+100.0%
1.54%
HUM BuyHUMANA INC$123,132,000
+82.0%
603,500
+57.8%
1.42%
+43.4%
FIS BuyFIDELITY NATL INFORMATION SV$113,831,000
+15.9%
1,504,909
+18.1%
1.31%
-8.6%
SSNC BuySS&C TECHNOLOGIES HLDGS INC$109,134,000
+0.6%
3,815,869
+13.1%
1.26%
-20.7%
RDUS BuyRADIUS HEALTH INC$81,004,000
-4.6%
2,130,000
+35.7%
0.93%
-24.8%
ACAS BuyAMERICAN CAP LTD$77,146,000
+256.4%
4,305,000
+236.3%
0.89%
+181.0%
BuySOLARCITY CORPnote 2.750%11/0$67,065,000
+21.5%
72,065,000
+4.7%
0.77%
-4.3%
TWX NewTIME WARNER INCput$55,022,000570,000
+100.0%
0.63%
YHOO NewYAHOO INC$44,857,0001,160,000
+100.0%
0.52%
H BuyHYATT HOTELS CORP$33,930,000
+1966.4%
614,000
+1740.9%
0.39%
+1529.2%
SLD NewSUTHERLAND ASSET MGMT CORP M$31,261,0002,324,236
+100.0%
0.36%
VIP BuyVIMPELCOM LTDsponsored adr$30,716,000
+52.4%
7,978,100
+37.8%
0.35%
+20.4%
AET NewAETNA INC NEW$20,090,000162,000
+100.0%
0.23%
LLY NewLILLY ELI & CO$19,859,000270,000
+100.0%
0.23%
BMY NewBRISTOL MYERS SQUIBB CO$18,116,000310,000
+100.0%
0.21%
FGEN BuyFIBROGEN INC$16,735,000
+259.3%
782,000
+247.6%
0.19%
+183.8%
GWPH BuyGW PHARMACEUTICALS PLCads$16,531,000
+301.7%
147,928
+377.2%
0.19%
+216.7%
PX NewPRAXAIR INC$15,088,000128,750
+100.0%
0.17%
WR NewWESTAR ENERGY INC$13,806,000245,000
+100.0%
0.16%
LVLT NewLEVEL 3 COMMUNICATIONS INC$12,117,000215,000
+100.0%
0.14%
COL NewROCKWELL COLLINS INC$11,595,000125,000
+100.0%
0.13%
AZN NewASTRAZENECA PLCsponsored adr$9,972,000365,000
+100.0%
0.12%
ABBV NewABBVIE INC$10,019,000160,000
+100.0%
0.12%
HZNP NewHORIZON PHARMA PLC$9,870,000610,000
+100.0%
0.11%
GILD NewGILEAD SCIENCES INC$9,667,000135,000
+100.0%
0.11%
GLPG NewGALAPAGOS NVspon adr$5,838,00090,955
+100.0%
0.07%
PCO NewPENDRELL CORPcl a new$5,542,000821,061
+100.0%
0.06%
CAB BuyCABELAS INC$4,684,000
+115.5%
80,000
+102.2%
0.05%
+68.8%
AKAOQ NewACHAOGEN INC$4,557,000350,000
+100.0%
0.05%
STML NewSTEMLINE THERAPEUTICS INC$2,755,000257,500
+100.0%
0.03%
GCVRZ BuySANOFIright 12/31/2020$2,595,000
+239.7%
6,827,805
+141.5%
0.03%
+172.7%
ILMN NewILLUMINA INC$2,433,00019,000
+100.0%
0.03%
PTLA NewPORTOLA PHARMACEUTICALS INC$2,244,000100,000
+100.0%
0.03%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP41Q3 20233.7%
RADIUS HEALTH INC33Q2 20221.7%
GRIFOLS S A33Q4 20210.9%
ALPHABET INC32Q3 20234.2%
SPDR S&P 500 ETF TR31Q3 202325.3%
VISA INC30Q3 20232.9%
WABTEC CORP27Q3 20233.6%
EXELIXIS INC27Q3 20232.8%
ELEVANCE HEALTH INC26Q3 20232.6%
SAVARA INC26Q3 20230.3%

View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.

Latest significant ownerships (13-D/G)
FARALLON CAPITAL MANAGEMENT LLC Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Atento S.A.March 15, 20232,230,35715.4%
Metals Acquisition CorpFebruary 07, 20232,489,7009.4%
Inflection Point Acquisition Corp.February 06, 20231,900,0005.8%
AMYRIS, INC.February 24, 20221,068,9040.3%
Swiftmerge Acquisition Corp.February 14, 2022291,0601.3%
Caribou Biosciences, Inc.February 11, 20222,428,1504.0%
ENANTA PHARMACEUTICALS INCFebruary 11, 2022287,0001.4%
Protagonist Therapeutics, IncFebruary 11, 2022387,0510.8%
Solid Power, Inc.February 11, 2022? ?
Better Therapeutics, Inc.February 09, 2022124,0650.5%

View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-05-15
13F-HR/A2024-05-15
13F-HR2024-05-15
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14

View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export FARALLON CAPITAL MANAGEMENT LLC's holdings